Stanford Medicine Taps Komodo Health Platform to Study COVID-19 Ripple Effects

Stanford Medicine Taps Komodo Health Platform to Study COVID-19 Ripple Effects

What You Should Know:

– Today, Komodo Health announced that its platform will be used in studies led by Stanford Medicine focused on the short- and long-term health impacts of COVID-19. 

– Stanford’s Center for Population Health Sciences will use Komodo Health’s platform, AI analytics tools, and de-identified patient data to study the real-world effects of the pandemic on health outcomes among different patient populations. Initial research will include analyses of disparities in access to COVID-19 testing and quality care; the impact of COVID-19 and the COVID-19 vaccine on various health conditions; and how cancer survival, treatment, and outcomes changed during the pandemic.

– As Stanford works to understand the myriad of factors that play a role in health complications that can arise post-COVID or when/why a treatment doesn’t work for patients, the ability to extract learnings from data that offers a comprehensive view of patient experiences – pre and post COVID-19 – will help its researchers investigate how unique patient characteristics impact symptoms, treatment, care and more.